Daniel Mrak, MD

Medical University of Vienna
Vienna, Austria

Lupus research

Disclosure information not submitted.

Presentation(s):

• 0701: Reduced Humoral but Maintained Cellular Immune Response to a 3^rd COVID-19 Vaccination in Patients with Immune-Mediated Inflammatory Diseases as Compared to Healthy Controls over a 3-months Observational Period

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0702: Fourth SARS-CoV-2 Vaccine Dose in Rituximab Treated Patients: An Open Label Extension Study

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time